Lipid-lowering effect of 2 dosages of a soy protein supplement in hypercholesterolemia

Advances in Therapy

Volumn 22, Issue 2, 2005, Pages 175-186

  Høie, Lars H ^a,d   Graubaum, Hans Joachim ^b   Harde, Andrea ^b   Gruenwald, Joerg ^b   Wernecke, Klaus D ^c  

^a Nutri Pharma ASA   (Norway)

^b PhytoPharm Consulting   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d c/o Nutri Pharma ASA ^*  (Norway)

Author keywords

Blood lipids; Cardiovascular disease; Cholesterol; Nutritional supplements; Soy protein

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; PLACEBO; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; SCREENING; TREATMENT OUTCOME;

EID: 21044440614     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849888     Document Type: Article

References (26)

1. Riesen WF. Fettstoffwechsel. In: Thomas L, ed. Labor und Diagnose. Frankfurt/Main, Germany: TH-Books Verlagsgesellschaft mbH; 1998:171-190.
2. Brönstrup A, Pietrzik K. Bedeutung von Homocysteine bei der Entstehung von Atherosklerose: ist eine Supplementierung von Vitaminen sinnvoll? Ernährungs-Umschau. 1996;43:80-87.
3. Müller-Bohn T. Atheroskleroseprophylaxe-Bericht zum Fortbildungskongress In Malente. Deutsche Apotheker-Zeitung. 1996;136:2453-2458.
4. Shepherd J, Cobbe SM, Ford I, et al. Prävention der KHK durch Pravastatin bei Männern mit Hypercholesterinämie. Manch Med Wschr. 1996;138:21-28.
5. Glore SR, an Treeck D, Knehans AW, Guild M. Soluble fiber and serum lipids: a literature review. J Am Diet Assoc. 1994;94:425-436.
6. Peters P, Peters KM, Saborowski F, et al. Lipidsenkung mit Ballaststoffen. Akt Ernähr-Med. 1990;15:119-122.
7. Messena M, Erdman JW Jr, eds. First international symposium on the role of soy in preventing and treating chronic disease. J Nutr. 1995;125(suppl):567S- 808S.
8. Sirtori CR, Lovati MR, Manzoni C, et al. Reductions of serum cholesterol by soy proteins: clinical experience and potential molecular mechanism. Nutr Metab Cardiovasc Dis. 1998;8:334-340.
9. Gianazza E, Eberini I, Arnoldi A, Wait R, Sirtori CR. A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies. J Nutr. 2003;133:9-14.
10. Anderson JW. Diet first, then medication for hypercholesterolemia. JAMA. 2003;290:531-533.
11. Lovati MR. Alfa prime subunit of soybean beta conglycinin: in vitro and in vivo activity on cholesterol homeostasis. Presented at: 5th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; September, 2003; Orlando, Fla.
12. Tsai AC, Mott EL, Owen GM, Bennick MR, Lo GS, Steinke FH. Effects of soy polysaccharide on gastrointestinal functions, nutrient balance, steroid excretions, glucose tolerance, serum lipids, and other parameters in humans. Am J Clin Nutr. 1983;38:504-511.
13. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence. J Clin Endocrinol Metab. 1998;83:2223-2235.
14. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276-282.
15. Baum JA, Teng H, Erdman JW, et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr. 1998;68:545-551.
16. Wong WW, Smith EOB, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr. 1998;68(suppl):1385S-1389S.
17. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteine. Arch Intern Med. 1999;159:2070-2076.
18. Washburn S, Burke GL, Morgan T, Anthony M. Effects of soy protein supplementation on serum lipoproteine, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999;6:7-13.
19. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000;71:1462-1469.
20. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Hassler CM. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr. 2000;71:1077-1084.
21. Hermansen K, Sondergaard M, Høie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 2001;24:228-233.
22. Puska P, Korpelainen V, Høie LH, Sksovlund E, Lahti E, Smerud KT. Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial. Eur J Clin Nutr. 2002;56:352-357.
23. Tonstad S, Smerud KT, Høie LH. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteine, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr. 2002;76:78-84.
24. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr. 2000; 73:225-231.
25. Brunner E, Domhof S, Langer F. Nonpammetric Analysis of Longitudinal Data in Factorial Experiments. New York, NY: Wiley & Sons; 2002.
26. Bathke A, Brunner E. A nonparametric alternative to analysis of covariance. In: Akritas MG, Politis DN, eds. Recent Advances and Trends in Nonparametric Statistics. Amsterdam, the Netherlands: Elsevier BV; 2003:109-120.